SPY336.84+0.01 0.00%
DIA279.80+0.38 0.14%
IXIC11,019.30-23.20 -0.21%

Cerevel Therapeutics Reports Business Combo With Arya Sciences Acquisition Corp. II; Upon Completion, Combined $445M In Expected Net Proceeds From PIPE, Cash Held In Arya II's Trust Account Will Be Used To Advance Development Of Cerevel's Neurosciene Pipe

Benzinga · -